USP30 and hepatocellular carcinoma: Its pathophysiological significance extends to cancer, where dysregulation of USP30 promotes hepatocellular carcinoma (HCC) through the IKKβ‐USP30‐ACLY lipogenesis axis [27] and drives breast cancer progression via Snail stabilization [28].